Fingerprint
Dive into the research topics of 'The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study
Jeanne C. Latourelle*, Mei Sun, Mark F. Lew, Oksana Suchowersky, Christine Klein, Lawrence I. Golbe, Margery H. Mark, John H. Growdon, G. Frederick Wooten, Ray L. Watts, Mark Guttman, Brad A. Racette, Joel S. Perlmutter, Anwar Ahmed, Holly A. Shill, Carlos Singer, Stefano Goldwurm, Gianni Pezzoli, Michela Zini, Marie H. Saint-Hilaire
*Corresponding author for this work
- Boston University School of Medicine
- Harvard University
- University of Southern California
- University of Calgary
- University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School
- University of Virginia
- University of Alabama
- University Health Network
- Washington University in St. Louis
- Barrow Neurological Institute
- Sun Health Research Institute
- University of Miami
- Istituti Clinici di Perfezionamento
- Cleveland Clinic Foundation
- University of Louisville School of Medicine
- University of Sydney
- Park Nicollet Health Services
- Port City Neurology
- Parkinson's Disease and Movement Disorder Center of Boca Raton
- Newcastle University
- European Academy Bozen
- University of Arkansas
- Aarhus University
- University of Arizona
- Auckland City Hospital
- University of Kentucky
94
Citations
(Scopus)